Skip to main content
Clinical Trials/NCT02112331
NCT02112331CompletedNot Applicable

Influence of Physical Treatments of Human Milk on the Kinetics of Gastric Lipolysis in Preterm Newborns

Rennes University Hospital2 sites in 1 country20 target enrollmentStarted: April 1, 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
20
Locations
2
Primary Endpoint
Percentage of triacylglycerol hydrolysis

Study Overview

Brief Summary

The optimization of newborns nutrition is a challenge especially for preterm newborns for whom nutrition plays a crucial part in cerebral and global development. Human milk is considered as the best food for newborns. Several short and long-term beneficial health effects were attributed to breastfeeding and have induced the increase of human milk in preterm newborns nutrition.

Whereas the chemical composition of infant formula has been optimized to mimic human milk, there is still a major difference between the structure of human milk and commercial infant formulas. It is well known in adult nutrition that the structure of emulsions influences their susceptibility to hydrolysis, such results have been obtained either on in vitro or in vivo studies.

Human milk is a natural emulsion (oil in water). Lipids droplets are dispersed under the form of entities called milk fat globules (average diameter 4 µm, span 0.1-20 μm). The globules are stabilized by a trilayered membrane composed mainly of polar lipids (phospholipids, sphingolipids and gangliosides), of proteins, neutral lipids and other minor compounds.

The physical treatments apply to human milk or more generally to bovine milk to pasteurize or stabilize the milk modify the structure of the natural emulsion. Heat treatment for instance induces whey proteins denaturation and the adsorption of protein aggregates on the surface of the milk fat globules. Heat treatment also leads to the denaturation of bile salt stimulated lipase. These effects limit intragastric lipolysis in preterm newborns.

Conversely, reduction of milk globules size, by homogenisation of milk, increases the specific surface available for lipase adsorption and limits the lost of fat during enteral administration of milk. Such treatment could thus enhance gastric lipolysis and improve fat absorption of preterm newborns.

The objective of this trial is to evaluate the effects of physical treatments (pasteurization and homogenisation by ultrasonication) applied to human milk on gastric lipolysis and milk destructuration. This trial is conducted, in vivo, on preterm newborns.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
5 Days to 21 Days (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Premature neonates born before 32 weeks of gestation
  • Newborn dwelled near Rennes
  • Volume of enteral nutrition > 120 mL/kg/j (Day 0)
  • Written-informed parental consent for the study

Exclusion Criteria

  • Digestive congenital anomalies
  • Antecedent of enterocolitis
  • Patient included in other study
  • Abdominal distension on Day 0
  • Treatment by morphine or catecholamine on Day 0

Outcomes

Primary Outcomes

Percentage of triacylglycerol hydrolysis

Time Frame: 35 min

Monitoring of the lipolysis kinetics, using chromatography methods

Secondary Outcomes

  • Fat composition(35 min, 60 min, 90 min)
  • Kinetic of the gastric emptying(35 min, 60 min, 90 min)
  • Lipolysis products(35 min, 60 min, 90 min)
  • Proteolysis products(35 min, 60 min, 90 min)
  • Percentage of triacylglycerol hydrolysis(60 min, 90 min)
  • Percentage of free fatty acids appearing(35 min, 60 min, 90 min)
  • Size distribution and specific surface of milk fat globule by laser light scattering(35 min, 60 min, 90 min)
  • Lipolysis level(35 min, 60 min, 90 min)

Investigators

Sponsor
Rennes University Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Influence of Physical Treatments of Human... | Clinical Trial